These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

563 related items for PubMed ID: 23833294

  • 1. Molecular and cellular aspects of calcific aortic valve disease.
    Towler DA.
    Circ Res; 2013 Jul 05; 113(2):198-208. PubMed ID: 23833294
    [Abstract] [Full Text] [Related]

  • 2. Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease.
    Bosse K, Hans CP, Zhao N, Koenig SN, Huang N, Guggilam A, LaHaye S, Tao G, Lucchesi PA, Lincoln J, Lilly B, Garg V.
    J Mol Cell Cardiol; 2013 Jul 05; 60():27-35. PubMed ID: 23583836
    [Abstract] [Full Text] [Related]

  • 3. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
    Gee T, Farrar E, Wang Y, Wu B, Hsu K, Zhou B, Butcher J.
    Arterioscler Thromb Vasc Biol; 2020 Mar 05; 40(3):638-655. PubMed ID: 31893948
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and cellular response feedback in calcific aortic valve disease.
    Gould ST, Srigunapalan S, Simmons CA, Anseth KS.
    Circ Res; 2013 Jul 05; 113(2):186-97. PubMed ID: 23833293
    [Abstract] [Full Text] [Related]

  • 5. Pathophysiology of valvular heart disease.
    Zeng YI, Sun R, Li X, Liu M, Chen S, Zhang P.
    Exp Ther Med; 2016 Apr 05; 11(4):1184-1188. PubMed ID: 27073420
    [Abstract] [Full Text] [Related]

  • 6. Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells.
    Sun JT, Chen YY, Mao JY, Wang YP, Chen YF, Hu X, Yang K, Liu Y.
    J Cardiovasc Transl Res; 2019 Dec 05; 12(6):560-568. PubMed ID: 31367900
    [Abstract] [Full Text] [Related]

  • 7. Cell-Type Transcriptome Atlas of Human Aortic Valves Reveal Cell Heterogeneity and Endothelial to Mesenchymal Transition Involved in Calcific Aortic Valve Disease.
    Xu K, Xie S, Huang Y, Zhou T, Liu M, Zhu P, Wang C, Shi J, Li F, Sellke FW, Dong N.
    Arterioscler Thromb Vasc Biol; 2020 Dec 05; 40(12):2910-2921. PubMed ID: 33086873
    [Abstract] [Full Text] [Related]

  • 8. Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.
    Porras AM, Shanmuganayagam D, Meudt JJ, Krueger CG, Hacker TA, Rahko PS, Reed JD, Masters KS.
    J Am Heart Assoc; 2015 Oct 27; 4(10):e002254. PubMed ID: 26508741
    [Abstract] [Full Text] [Related]

  • 9. Augmented osteogenic responses in human aortic valve cells exposed to oxLDL and TLR4 agonist: a mechanistic role of Notch1 and NF-κB interaction.
    Zeng Q, Song R, Ao L, Xu D, Venardos N, Fullerton DA, Meng X.
    PLoS One; 2014 Oct 27; 9(5):e95400. PubMed ID: 24810405
    [Abstract] [Full Text] [Related]

  • 10. High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1.
    El Husseini D, Boulanger MC, Fournier D, Mahmut A, Bossé Y, Pibarot P, Mathieu P.
    PLoS One; 2013 Oct 27; 8(1):e53393. PubMed ID: 23308213
    [Abstract] [Full Text] [Related]

  • 11. Interstitial cells in calcified aortic valves have reduced differentiation potential and stem cell-like properties.
    Bogdanova M, Zabirnyk A, Malashicheva A, Enayati KZ, Karlsen TA, Kaljusto ML, Kvitting JP, Dissen E, Sullivan GJ, Kostareva A, Stensløkken KO, Rutkovskiy A, Vaage J.
    Sci Rep; 2019 Sep 10; 9(1):12934. PubMed ID: 31506459
    [Abstract] [Full Text] [Related]

  • 12. Ex vivo evidence for the contribution of hemodynamic shear stress abnormalities to the early pathogenesis of calcific bicuspid aortic valve disease.
    Sun L, Chandra S, Sucosky P.
    PLoS One; 2012 Sep 10; 7(10):e48843. PubMed ID: 23119099
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A, Kistner J, Saradar S, Chekhoeva A, Yazdanyar M, Bergmann AK, Rötepohl MV, Lichtenberg A, Akhyari P.
    Am J Physiol Heart Circ Physiol; 2020 Nov 01; 319(5):H1123-H1141. PubMed ID: 32986963
    [Abstract] [Full Text] [Related]

  • 14. Insights into the use of biomarkers in calcific aortic valve disease.
    Beckmann E, Grau JB, Sainger R, Poggio P, Ferrari G.
    J Heart Valve Dis; 2010 Jul 01; 19(4):441-52. PubMed ID: 20845891
    [Abstract] [Full Text] [Related]

  • 15. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
    Pasipoularides A.
    J Cardiovasc Transl Res; 2016 Apr 01; 9(2):102-18. PubMed ID: 26891845
    [Abstract] [Full Text] [Related]

  • 16. Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments.
    Myasoedova VA, Ravani AL, Frigerio B, Valerio V, Moschetta D, Songia P, Poggio P.
    Pharmacol Res; 2018 Oct 01; 136():74-82. PubMed ID: 30149054
    [Abstract] [Full Text] [Related]

  • 17. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.
    Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, Hofmann-Bowman MA, Mortlock DP, Rogers MB, Sadeghi MM, Aikawa E.
    Arterioscler Thromb Vasc Biol; 2014 Nov 01; 34(11):2387-93. PubMed ID: 25189570
    [Abstract] [Full Text] [Related]

  • 18. Identification of hub genes in calcific aortic valve disease.
    Lai QC, Zheng J, Mou J, Cui CY, Wu QC, M Musa Rizvi S, Zhang Y, Li TM, Ren YB, Liu Q, Li Q, Zhang C.
    Comput Biol Med; 2024 Apr 01; 172():108214. PubMed ID: 38508057
    [Abstract] [Full Text] [Related]

  • 19. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
    Mahmut A, Boulanger MC, El Husseini D, Fournier D, Bouchareb R, Després JP, Pibarot P, Bossé Y, Mathieu P.
    J Am Coll Cardiol; 2014 Feb 11; 63(5):460-9. PubMed ID: 24161325
    [Abstract] [Full Text] [Related]

  • 20. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF, Wu PJ, Tibbitt MW, van Mil A, Sluijter JP, Langer R, Aikawa E.
    Clin Sci (Lond); 2017 Feb 01; 131(3):181-195. PubMed ID: 28057890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.